Sunday, September 19

Fase 2

coronavirus, Covid 19, dosis de refuerzo, ensayos, Fase 2, janssen, Johnson & Johnson, Noticias, Salud, vacuna, Variante Delta

Johnson & Johnson: Our Booster Dose Is Very Powerful | Digital Trends Spanish

According to data provided by Johnson & Johnson, a booster dose of its COVID-19 vaccine significantly increased antibody levels. These are provisional data from two early stage trials. According to the information, the second injection was given between six and eight months after the first. People who received a booster saw their binding antibodies rise nine times more than 28 days after the first injection, the company explained in a statement. "With this new data, we also see that a booster dose of Johnson & Johnson COVID-19 vaccine further increases antibody responses among study participants who had already received our vaccine," said Mathai Mammen, head of research and development of J & J's Janssen pharmaceutical division. "We look forward to discussing with public health officia...